Crohn’s Disease CD4+ T Cells

About Crohn’s Disease CD4+ T Cells

Crohn’s Disease CD4+ T Cells

CD4+ Helper T Cells for Gastrointestinal Immune Research

Human CD4+ T Cells are purified from peripheral blood of IRB-consented donors diagnosed with Crohn’s disease. These cells play a significant role in chronic intestinal inflammation and mucosal immune dysregulation, supporting studies of T helper cell polarization and immune responses in gastrointestinal disease.

Product Features

  • Research Use Only (RUO), CD4 positive T cells
  • Isolated from clinically confirmed Crohn’s disease donors
  • High purity and viability (≥90% CD4+ cells)
  • Cryopreserved in CryoStor® CS10 media
  • Processed within 24 hours of collection
  • IRB-approved protocols with electronic informed consent

Donor Metadata

  • Verified diagnosis and clinical background
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Treatment history when available

Applications

  • Mucosal immunity studies
  • Th17 and inflammatory pathway research
  • Gut immune modeling
  • Immune therapeutic evaluation

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11–compliant e-consent system
  • HIPAA-compliant data management

Ordering & Customization

Human CD4+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability.

Applications

  • Immunology and translational research
  • Biomarker discovery and validation
  • Drug screening and assay development
  • Vaccine and infectious disease research

Product Features

  • Research Use Only (RUO), CD4+ T Cells
  • Sourced from screened, consented donors
  • Processed under validated SOPs
  • QC tested for purity, viability, and sterility
  • Processed within 24 hours of collection
  • IRB-approved protocols with electronic informed consent

Donor Metadata

  • Verified diagnosis and clinical history
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Medication and treatment background when available

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11-compliant e-consent system
  • HIPAA-compliant data management

Ordering & Customization

Human CD4+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Need a custom CD4+ T Cells cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information